- Home
- HNVR vs VOR Comparison
HNVR vs VOR Comparison
Compare HNVR & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNVR
- VOR
- Stock Information
- Founded
- HNVR 2008
- VOR 2015
- Country
- HNVR United States
- VOR United States
- Employees
- HNVR N/A
- VOR N/A
- Industry
- HNVR Commercial Banks
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- HNVR Finance
- VOR Health Care
- Exchange
- HNVR Nasdaq
- VOR Nasdaq
- Market Cap
- HNVR 163.2M
- VOR 134.8M
- IPO Year
- HNVR 2022
- VOR 2021
- Fundamental
- Price
- HNVR $22.32
- VOR $0.72
- Analyst Decision
- HNVR Buy
- VOR Strong Buy
- Analyst Count
- HNVR 1
- VOR 7
- Target Price
- HNVR $22.00
- VOR $9.43
- AVG Volume (30 Days)
- HNVR 10.4K
- VOR 269.5K
- Earning Date
- HNVR 04-16-2025
- VOR 03-20-2025
- Dividend Yield
- HNVR 1.81%
- VOR N/A
- EPS Growth
- HNVR N/A
- VOR N/A
- EPS
- HNVR 1.66
- VOR N/A
- Revenue
- HNVR $63,491,000.00
- VOR N/A
- Revenue This Year
- HNVR N/A
- VOR N/A
- Revenue Next Year
- HNVR $16.61
- VOR N/A
- P/E Ratio
- HNVR $13.64
- VOR N/A
- Revenue Growth
- HNVR 5.04
- VOR N/A
- 52 Week Low
- HNVR $13.62
- VOR $0.63
- 52 Week High
- HNVR $27.14
- VOR $2.43
- Technical
- Relative Strength Index (RSI)
- HNVR 42.19
- VOR 28.48
- Support Level
- HNVR $22.29
- VOR $0.75
- Resistance Level
- HNVR $23.00
- VOR $0.93
- Average True Range (ATR)
- HNVR 0.97
- VOR 0.07
- MACD
- HNVR 0.10
- VOR 0.00
- Stochastic Oscillator
- HNVR 48.00
- VOR 7.61
About HNVR Hanover Bancorp Inc.
Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.